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Abstract
We compared the efﬁcacy of three techniques—minimal time to positivity (MTTP) of blood cultures (BCs), differential time to positivity
(DTTP) of BCs obtained from the catheter and peripheral veins and the number of positive BCs—in predicting catheter involvement in
patients with well-demonstrated catheter-related candidaemia (C-RC) and non-catheter-related candidaemia (NC-RC).C-RC was deﬁned
as isolation of the same Candida species from blood and catheter tip culture ( 15 cfu/plate). A ROC curve was created for each
quantitative variable to determine the best cut-off for predicting C-RC.A total of 108 episodes of candidaemia were included (84 adults and
24 children; 67 C-RC and 41 NC-RC). These were caused mainly by C. albicans (49.1%) and C. parapsilosis (30.6%). The MTTP was
signiﬁcantly shorter in adult patients with C-RC than in those with NC-RC (29.8 vs. 36.8 hours; p 0.035), although no cut-off value
provided acceptable accuracy. DTTP had high sensitivity but low speciﬁcity for predicting CRC. However, C-RC episodes had a signiﬁcantly
greater number of positive BCs than NC-RC episodes. The optimal cut-off for predicting C-RC was at least two positive BCs out of three,
with the following validity values: sensitivity, 100%; speciﬁcity, 62.5%; positive predictive value, 83.3%; negative predictive value, 100%;
accuracy, 87.0%.None of the tests evaluated allow a clear-cut prediction of C-RC and the criteria accepted for bacteraemia should not be
automatically extrapolated to candidaemia. We found that a low number of positive BCs with Candida had a high negative predictive value
for a catheter origin.
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Introduction
Recognition of catheter involvement is essential for adequate
management of candidaemia, because withdrawal is recom-
mended when the catheter is the source of the infection [1–3].
However, in contrast to studies on catheter-related bacterial
infections [4,5], few reports analyse the accuracy of available
microbiological methods for determination of catheter
involvement in patients with candidaemia before catheter
removal.
In patients with bacteraemia, catheter-related bloodstream
infection (CR-BSI) can be diagnosed before catheter with-
drawal using techniques such as differential colony counts,
differential time to positivity (DTTP) in blood cultures (BCs)
obtained simultaneously from peripheral veins and the cath-
eter, and superﬁcial cultures from hubs and skin, which have a
high negative predictive value for catheter colonization [4–10].
However, the accuracy of these methods has not been
properly assessed in candidaemia, and such approaches can be
signiﬁcantly affected by factors such as Candida species or the
much slower growth of fungi in BCs. Accordingly, the efﬁcacy
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of accepted cut-offs for bacteraemia should be tested by
comparing their ability to differentiate catheter-related
candidaemia (C-RC) from non-catheter-related candidaemia
(NC-RC). To our knowledge, such a comparison has not been
performed in patients with candidaemia [11].
Information on minimal time to positivity (MTTP) of BCs for
discriminating between CR-BSI and non-CR-BSI in bacterial
infections is insufﬁcient. Ben-Ami et al. [12] suggested that
MTTP was a sensitive marker ( 30 h) in episodes of
candidaemia. However, no other authors have further inves-
tigated this method.
We assessed the efﬁcacy of MTTP, differential time to
positivity (DTTP) of peripheral vein and catheter BCs, and a
new option, the number of positive blood cultures (NPBC), as




Ours was a retrospective study carried out at a large teaching
hospital in Madrid, Spain. During the study period (1 July 2005
to 31 August 2010; 62 months) we included all candidaemic
patients with a central venous catheter (CVC) at the moment
of the episode and a catheter tip culture performed within
7 days after diagnosis of candidaemia. We then separated
patients into two groups according to catheter tip culture:
catheter-related candidaemia (C-RC) and non-catheter-related
candidaemia (NC-RC).
Deﬁnitions
Candidaemia: isolation of Candida species in at least one BC
obtained from a peripheral vein.
Catheter-related candidaemia: isolation of the same Candida
(genus and species) from the catheter tip (semiquantitative
culture,  15 cfu/plate) [13] and at least one BC obtained
from a peripheral vein. Those cases in which catheter tip
culture yielded 1–14 cfu/plate were excluded from the study.
Non–catheter-related candidaemia: semiquantitative culture
of the catheter tip that was negative or revealed a different
microorganism from the Candida species recovered in the
peripheral BC.
Polymicrobial fungaemias were excluded from the analysis.
Microbiological methods
Peripheral BCs. Peripheral BCs were obtained by drawing
approximately 10 mL of venous blood, which was inoculated
into Bactec aerobic and anaerobic bottles (Becton Dickinson
Microbiology Systems, Maryland, DE, USA). In general, two or
three BCs (from two or three different sites) were obtained in
adult patients and only one pair in paediatric patients. BCs
were processed according to routine methods using the semi-
automatic culture detector (Bactec 9240; Bactec Plus Aerobic/
F, Becton Dickinson Microbiology Systems). When the BC was
ﬂagged as positive and the Gram stain demonstrated the
presence of a yeast, a subculture was performed in Chrom-
Agar. The yeasts were identiﬁed using the API ID 32C
(bioMerieux, Marcy l’Etoile, France) [14,15].
Minimal time to positivity. Minimal time to positivity was deﬁned
as the time elapsed from the introduction of peripheral BCs in
the incubating machine to the moment the ﬁrst bottle turned
positive with Candida.
Differential time to positivity. Differential time to positivity
consisted of obtaining blood through all available catheter
lumens and through a peripheral vein in order to compare the
MTTP of each sample. According to the clinical practice
guidelines for the diagnosis and management of intravascular
catheter-related infections, catheter-related bacteraemia is
deﬁned as the growth of a microorganism from a blood sample
drawn from a catheter lumen at least 2 h before the same
microorganism is detected in a blood sample obtained from a
peripheral vein [5].
Number of positive blood cultures. We assessed the number of
peripheral BCs obtained and those that turned positive in both
C-RC and NC-RC.
Catheter tip culture. Catheter tips were cultured using the
semiquantitative roll-plate technique according to IDSA guide-
lines [5,13].
Data recorded
We recorded the following data: total number of BCs
obtained, number of BCs with Candida, MTTP in both
aerobic and anaerobic bottles and DTTP in patients with BC
obtained both from a peripheral vein and from catheter
lumens.
Data analysis
All patients with conﬁrmed C-RC episodes were considered
cases and patients with NC-RC were considered controls. We
performed separate analyses for adult and paediatric patients.
In some cases, a sub-analysis was performed for yeast species.
Each variable was compared between patients with C-RC and
NC-RC.
We performed the following analyses: a normality test
(Kolmogorov–Smirnov with Lilliefors signiﬁcance correction)
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for quantitative variables (MTTP and DTTP); two-tailed t-test
for normally distributed variables; two-tailed Mann–Whitney
test for non-normally distributed variables; receiver operating
characteristic (ROC) curve analysis to detect suitable values
for predicting C-RC; and two-tailed Fisher exact test to
analyse the value of the number of positive BCs with Candida.
A p value < 0.05 was considered signiﬁcant. Data were
entered into a database created using Access 2003, and SPSS
16.0 was used for statistical analysis.
Results
During the study period, in which 481 episodes of candidaemia
occurred in our institution, catheter tip culture was performed
within 7 days of the diagnosis of the episode in 151 episodes of
candidaemia. According to our design, 43 episodes (28.5%)
were excluded because they involved polymicrobial candida-
emia (17), previous candidaemia during the preceding
2 months (13), catheter tip culture with only 1–14 cfu of
Candida per plate (11), or incomplete data (2). Therefore, the
ﬁnal study sample comprised 108 episodes of candidaemia
from 107 patients. Overall, there were only two episodes of
candidaemia caused by tunneled catheters.
Epidemiological information
Overall, 24 episodes (22.2%) corresponded to 23 paediatric
patients and 84 episodes (77.8%) corresponded to 84 adult
patients. The distribution of Candida species is shown in
Table 1. Candida albicans accounted for 49.1% and C. parapsi-
losis for 30.6% of all episodes.
According to CVC tip culture, 62.0% of the candidaemia
episodes (67 from 108) were C-RC. The proportion of C-RC
in the paediatric and adult populations was, respectively, 45.8%
(11 from 24 episodes) and 66.7% (56 from 84 episodes). When
we compared the species causing CR-C and NC-RC in the
paediatric population, we could not ﬁnd statistically signiﬁcant
differences. However, in adults C. parapsilosis tended to be
more frequent in the C-RC group (33.9% vs. 14.3%;
p 0.072).
MTTP of peripheral BCs
Overall, MTTP in CR-C and NC-RC episodes was 28.5 vs.
31.2 h (p 0.115). In Table 2 we analyse the validity values of
different MTTP cut-offs as predictors of C-RC in adult
patients. The proposed cut-off of  30 h [12] revealed the
following validity values for predicting C-RC: sensitivity, 50.0%;
speciﬁcity, 60.7%; positive predictive value, 71.8%; negative
predictive value, 37.8%; accuracy, 53.6%. We found <55 h of
MTTP to be the most accurate cut-off (accuracy of 70.2%,
sensitivity 89.3% and speciﬁcity 28.6%).
We then analysed MTTP in children and adults (Table 3).
No signiﬁcant differences were found between C-RC and NC-
RC (25.3 vs. 23.2; p 0.608) in the paediatric population;
however, adult patients with C-RC had a shorter MTTP (29.8
vs. 36.8; p 0.035). The ROC curves conﬁrmed these data (area
under the curve (AUC) in the paediatric population 0.566 (95%
CI, 0.330–0.803; p 0.582); AUC in the adult population, 0.642
(95% CI, 0.516–0.767; p 0.035)).
When we studied the possible effect of Candida species in
adult patients, we observed that C. glabrata showed an
important difference in MTTP between patients with C-RC
and those with NC-RC (23.6 vs. 91.7 h); however, these
differences did not reach statistical signiﬁcance for any
individual species (Table 3).
Differential time to positivity
To analyse the utility of DTTP for diagnosing C-RC, we
selected the 24 candidaemic patients, all adults, in whom BCs
were simultaneously obtained from a peripheral vein and from
catheter lumens (median number of lumens evaluated, 2;
range, 1–4). Of these, 19 (79.2%) had C-RC. The aetiology in
the 24 episodes was similar to that of the global population:
C. albicans, 45.8%; C. parapsilosis, 25.0%.
DTTPs for C-RC and NC-RC were 19.9 and 4.4 h
(p 0.023; AUC = 0.811, p 0.036), respectively. If we had used
TABLE 1. Distribution of Candida species in 108 episodes of candidaemia in children and adultsa
Species All episodes (%)
Adult episodes (N = 84) Paediatric episodes (N = 24)
C-RC (%) NC-RC (%) p C-RC (%) NC-RC (%) p
C. albicans 53 (49.1) 27 (48.2) 13 (46.4) 1 6 (54.5) 7 (53.8) 1
C. parapsilosis 33 (30.6) 19 (33.9) 4 (14.3) 0.072 5 (45.5) 5 (38.5) 1
C. glabrata 12 (11.1) 6 (10.7) 5 (17.9) 0.494 – 1 (7.7) 1
C. tropicalis 5 (4.6) 3 (5.4) 2 (7.1) 1 – – –
C. guilliermondii 3 (2.8) 1 (1.8) 2 (7.1) 0.257 – – –
C. krusei 1 (0.9) – 1 (3.6) 0.333 – – –
C. dubliniensis 1 (0.9) – 1 (3.6) 0.333 – – –
All species 108 56 28 – 11 13 –
C-RC, catheter-related candidaemia; NC-RC, non-catheter-related candidaemia.
aValues expressed as No. (%).
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the cut-off value of  2 h accepted as a breakpoint to
differentiate catheter-related bacteraemia, the results of the
test to predict C-RC would have been as follows: sensitivity,
94.7%; speciﬁcity, 40%; positive predictive value, 85.7%;
negative predictive value, 66.7%; accuracy, 83.3%. The validity
values of the different DTTP cut-offs are shown in Table 4. No
single cut-off value showed sufﬁcient sensitivity and speciﬁcity
for clinical purposes.
Number of positive peripheral BCs
Finally, we analysed whether the number of positive BCs
indicated a catheter-related origin for candidaemia. The
distribution of the number of BCs taken in all episodes was
as follows: one BC in 40 episodes (37.0%; 18 from adults and
22 from children), two BCs in 22 episodes (20.4%; 20 from
adults and two from children), three BCs in 41 episodes
(38.0%; all adults), four BCs in one episode (0.9%; all adults),
ﬁve BCs in two episodes (1.8%; all adults), and six BCs in two
episodes (1.8%; all adults).
For the analysis of the predictive value of NPBC, all
episodes with only one BC were excluded, and the remaining
episodes were divided into two groups: episodes with at least
three BCs (46 episodes; 42.6%) (the ﬁrst 3 BCs were selected
for the analysis) and episodes with two BCs (22 episodes;
20.4%).
The best results were obtained among the 46 episodes with
at least three BCs (Table 5). Of these, 30 episodes were C-RC
and all of them had  2 positive BCs; therefore, the sensitivity,
speciﬁcity, positive predictive value, negative predictive value
and accuracy for this cut-off were 100%, 62.5%, 83.3%, 100%
and 87.0%, respectively.
Among the 22 episodes with two BCs, 15 were C-RC; both
BCs were positive in 13 (86.7%) episodes. The sensitivity,
speciﬁcity, positive predictive value, negative predictive value
and accuracy of detecting Candida in 2/2 BCs were 86.7%,
42.9%, 76.5%, 60.0% and 72.7%, respectively.
Discussion
We demonstrated that the diagnostic methods used to
establish a catheter as the origin of bacteraemia may not be
equally applicable to infections by Candida. In our experience,
the number of positive peripheral BCs ( 2) is the most useful
marker of catheter-related candidaemia (sensitivity 100% in
patients with three BCs), followed by the DTTP of BCs
obtained from a vein and from a catheter.
The Candida species is responsible for approximately 8% of
catheter-related bloodstream infections (CRBSIs) and is the
third most frequent cause of CRBSI associated with percuta-
neously inserted non-cuffed catheters after coagulase-negative
staphylococci and Staphylococcus aureus [16–19]. Guidelines
recommend withdrawing the catheter in patients with
candidaemia when there is evidence that the catheter is the
TABLE 2. Validity values of different cut-offs for minimal
time to positivity as a predictor of catheter-related candida-
emia in adult patients
Cut-off
(hours) Sensitivity % Speciﬁcity % PPV % NPV % Accuracy %
<15 3.6 96.4 66.7 33.3 34.5
<20 25.0 92.8 88.2 38.8 48.8
<25 33.9 82.1 76.0 45.8 54.8
<30a 50.0 60.7 71.8 37.8 53.6
<35 64.3 50.0 72.0 41.2 59.5
<40 76.8 46.4 74.1 50.0 66.7
<45 82.1 35.7 71.9 50.0 66.7
<50 85.7 28.6 71.0 53.3 67.9
<55b 89.3 28.6 71.8 61.5 70.2
<60 91.1 21.4 70.3 60.0 69.0
<65 92.9 21.4 70.3 60.0 69.0
<70 96.4 24.3 69.2 66.7 69.0
PPV, positive predictive value; NPV, negative predictive value.
aCut-off previously proposed for candidaemia.
bCut-off with the best accuracy for candidaemia.
TABLE 3. Minimal time to positivity according to Candida species in the 108 episodes of candidaemia included in the study
(median hours to growth)
Species
Adult episodes (84) a Paediatric episodes (24)a
C-RC (56) NC-RC (28) p C-RC (11) NC-RC (13) p
C. albicans 29.5 (20.6–36.9; 27) 34.7 (28.9–53.0; 13) 0.135 20.7 (12.6–32.7; 6) 23.2 (14.6–41.3; 7) 0.534
C. parapsilosis 32.5 (27.1–41.6; 19) 37.5 (53.9–92.2; 4) 0.667 25.3 (14.5–30.8; 5) 28.6 (8.0–42.3; 5) 0.690
C. glabrata 23.6 (16.1–74.4; 6) 91.7 (26.1–42.4; 5) 0.126 – 16.7 (ND; 1)
C. tropicalis 16.1 (13.5–16.4; 3) 23.7 (23.2–24.1; 2) 0.200 – –
C. guilliermondii 28.0 (ND; 1) 34.3 (26.1–42.4; 2) 1 – –
C. krusei – 13.5 (ND; 1) – – – –
C. dubliniensis – 29.4 (ND; 1) – – – –
All but C. glabrata 29.9 (20.4–38.6; 50) 30.8 (24.1–46.9; 23) 0.280 25.3 (12.6–28.5; 11) 25.9 (13.8–40.8; 12) 0.525
All 29.8 (19.7–39.2; 56) 36.8 (26.6–57.5; 28) 0.035 25.3 (12.6–28.5; 11) 23.2 (14.1–40.4; 13) 0.608
C-RC, catheter-related candidaemia; NC-RC, non-catheter-related candidaemia; ND, no data.
aValues between parentheses express interquartile range and number of episodes.
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source of infection or in patients for whom no source of
candidaemia is obvious, unless there are unusual extenuating
circumstances (e.g. no alternative catheter insertion site) [5].
However, this recommendation is controversial, owing to
the difﬁculties in establishing the origin of candidaemia before
catheter withdrawal, the associated costs of unnecessary
catheter removal, and the potential complications of new
catheter insertions. These difﬁculties in establishing a prompt
diagnosis have also inﬂuenced discussion in the literature
regarding the clinical beneﬁt of early removal [20]. Therefore,
clinicians must carefully consider the indication for catheter
withdrawal, especially in the case of tunneled CVCs that
require a surgical procedure for replacement [21–24].
There are some circumstances that may suggest the
involvement of the catheter, such as evidence of suppurative
phlebitis in a patient with candidaemia or isolation of C.
parapsilosis in an adult patient, but not in a paediatric patient, as
our data have proven [25,26]. However, in many instances, the
origin of the fungaemia is not clinically evident, and there is a
clear lack of microbiological techniques for reliably identifying
Candida-infected catheters without the need for withdrawal.
While laboratory microbiological procedures (e.g. differential
colony counts, DTTP, or superﬁcial culture) have proven
effective in catheter-related bacteraemia, they have not been
sufﬁciently tested in candidaemia [4,6–10].
Some authors attempted to diagnose C-RC with the
catheter in situ. Telenti et al. [27] found a good association
between intravascular device infection and high-grade candi-
daemia ( 25 cfu/10 mL in peripheral blood specimens). In
their prospective study of Candida bloodstream infections,
Ben-Ami et al. [12] observed that an MTTP of peripheral blood
of >30 h ruled out the CVC as the source of candidaemia
(100% sensitivity and 51.4% speciﬁcity for C-RC). Although we
also found MTTP to be signiﬁcantly shorter in adults with
catheter-related candidaemia (29.8 h vs. 36.8 h, p < 0.03), we
could not reproduce the favourable results of Ben-Ami et al.,
because none of the tested cut-offs were sufﬁciently efﬁcacious
for us to make clinical decisions. We calculated the validity
values for the prediction of C-RC in adult patients with the
 30 h suggested by Ben-Ami et al., and the results were as
follows: sensitivity, 50.0%; speciﬁcity, 60.7%; positive predictive
value, 71.8%; negative predictive value, 37.8%. We found the
best cut-off of MTTP for the prediction of C-RC in adults to be
<55 h, which had an accuracy of 70.2%. In our opinion, this is
still too low for clinical practice. We have separated data from
paediatric and adult patients, because the different inocula and
different species in both populations could greatly inﬂuence
the time to positivity of BCs. Thus, according to the MTTP in
candidaemia due to C. glabrata, we found that MTTPs of
NC-RC episodes were greater than those obtained from other
species, which may be partially explained by the fact that
Bactec bottles, especially those that are aerobic, do not
perform well in candidaemia due to this agent, with typical late
diagnosis.
BCs obtained from both the catheter and a peripheral vein
provide the DTTP, which is useful for bacterial catheter-
related infections. In our experience, DTTP in candidaemic
patients had high sensitivity but low speciﬁcity for predicting
whether candidaemia was related to the CVC, especially
when the cut-off was set at >1 h. When the cut-off was set
TABLE 5. Number of positive blood cultures and validity values for prediction of catheter-related candidaemia in patients with at
least two blood cultures
Number of BCs extracted Candidaemia type (n)
Number of positive BCs
Validity values (%) for a cut-off of
 2 positive BCs for C-RC
prediction
Validity values (%) for a cut-off
of 3 positive BCs for C-RC
prediction
1/2 2/2 S SP PPV NPV A
Two C-RC (15) 2 (13.3%) 13 (86.7%) 86.7 42.9 76.5 60.0 72.7 Not applicable
NC-RC (7) 3 (42.9%) 4 (57.1%)
p 0.274
1 /3 2/3 3/3 S SP PPV NPV A S SP PPV NPV A
Three C-RC (30) – 3 (10.0%) 27 (90.0%) 100 62.5 83.3 100 87.0 90.0 62.5 81.8 76.9 80.4
NC-RC (16) 10 (62.5%) – 6 (37.5%)
p < 0.001
BCs, blood cultures; S, sensitivity; SP, speciﬁcity; PPV, positive predictive value; NPV, negative predictive value; A, accuracy; C-RC, catheter-related candidaemia; NC-RC, non-
catheter-related candidaemia.
TABLE 4. Validity values of different cut-offs of differential
time to positivity as predictors of catheter-related candida-
emia in adult patients
DTTP
cut-off
(hours) Sensitivity % Speciﬁcity % PPV % NPV % Accuracy %
>1a 100 20.0 82.6 100 83.3
>2a,b 94.7 40.0 85.7 66.7 83.3
>3a 94.7 40.0 85.7 66.7 83.3
>4 89.5 40.0 85.0 50.0 79.2
>5a 89.5 60.0 89.5 60.0 83.3
>6 78.9 60.0 88.2 42.9 75.0
DTTP, differential time to positivity; PPV, positive predictive value; NPV, negative
predictive value.
aCut-off with the best accuracy for candidaemia.
bCut-off previously proposed for bacteraemia.
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at >2 h, >3 h or >5 h, we obtained better accuracy values
(83.3% for >5 h). However, in our opinion, once again, none
of these cut-off values are sufﬁciently accurate for clinical
practice.
In contrast, our best validity values for predicting C-RC
were obtained with an NPBC >2, mainly in patients with
three BC samples. By analysing the performance of this test
in patients with three BCs, we minimize the potential bias of
undetected differences in patients with different numbers of
obtained BCs. Catheter-related infection is usually continu-
ous; therefore, according to our data, when <2 BCs are
positive in a candidaemic patient for whom at least three BCs
have been obtained, the probability that the catheter is the
origin of the infection is extremely low, and other sources
should be investigated. We believe this is a simple and
practical method that may be clinically useful if validated by
other authors.
The main limitation of our study is its retrospective design,
which made it impossible to compare all available techniques in
every patient. Another limitation was the deﬁnition of C-RC
made on the basis of tip culture, as some NC-RCs could not
be clearly established because the tip was not sent for culture
(as the clinician did not suspect a C-RC). This could be
reﬂected by the high rate of C-RC (62%). Moreover, in some
cases, the statistical analysis was hampered by the small sample
size, such as the DTTP. Thus, future prospective studies must
be performed. However, our data constitute the best available
information to date and provide practical information for the
management of candidaemia.
We conclude that, of all the tests evaluated, only the
number of positive BCs allows a clear-cut prediction of C-RC.
The criteria accepted for bacteraemia should not be automat-
ically extrapolated to candidaemia.
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